|
|
|
|
| LEADER |
01232 am a22001813u 4500 |
| 001 |
91645 |
| 042 |
|
|
|a dc
|
| 100 |
1 |
0 |
|a Hammond, Paula T
|e author
|
| 100 |
1 |
0 |
|a Massachusetts Institute of Technology. Department of Chemical Engineering
|e contributor
|
| 100 |
1 |
0 |
|a Koch Institute for Integrative Cancer Research at MIT
|e contributor
|
| 100 |
1 |
0 |
|a Hammond, Paula T.
|e contributor
|
| 245 |
0 |
0 |
|a Building biomedical materials layer-by-layer
|
| 260 |
|
|
|b Elsevier,
|c 2014-11-20T14:58:30Z.
|
| 856 |
|
|
|z Get fulltext
|u http://hdl.handle.net/1721.1/91645
|
| 520 |
|
|
|a In this materials perspective, the promise of water based layer-by-layer (LbL) assembly as a means of generating drug-releasing surfaces for biomedical applications, from small molecule therapeutics to biologic drugs and nucleic acids, is examined. Specific advantages of the use of LbL assembly versus traditional polymeric blend encapsulation are discussed. Examples are provided to present potential new directions. Translational opportunities are discussed to examine the impact and potential for true biomedical translation using rapid assembly methods, and applications are discussed with high need and medical return.
|
| 546 |
|
|
|a en_US
|
| 655 |
7 |
|
|a Article
|
| 773 |
|
|
|t Materials Today
|
